Font Size: a A A

Clinical Application By Using Shenguijingxue Decoction To Treat Delayed Menstrual Cycle

Posted on:2012-08-25Degree:DoctorType:Dissertation
Country:ChinaCandidate:Z Y LinFull Text:PDF
GTID:1114330335977635Subject:TCM gynecology
Abstract/Summary:PDF Full Text Request
Objective:Though comparing the clinical efficacy before and after the treatment to determine the efficacy of shenguijingxue soup to treat with late menstrual deficiency, analyze "qi, essence, blood" theories exert in clinic, so as to research the ideas and methods to treat with gynecology problems.Methods:We collected cases of late menstrual deficiency patients by using 8-10 bags of shengui jingxue soup to treat with menstruation. Observe and analyze the main syndromes, secondary changes in symptoms, use the methods before and after treatment to determine efficacy. Analysis the treatment ideas of shenguijingxue soup and put forward the unfinished issues.Results:53 patients in this group. After treatment:1. Menstruation and pregnancy conditions(1) There are 53 patients with late menstrual deficiency. After treatment,31 patients(58.49%) with post-menstrual cycle returned to normal period,10 petients(18.87%) have at least 7-days-shorter-period than before treatment, and 4 patients (9.30%) pregnancy. The t test, t =4.0028, p=0.0002<0.01, that before and after treatment are significantly different.(2) There are 42 patients with no significant associated syndrome (which is included in post-menstrual cycle). After treatment,27 patients(64.29%) returned to normal period,6 petients(14.29%) have at least 7-days-shorter-period than before treatment, and 4 patients (9.52%) pregnancy. The t test, t= 3.544, p=0.001<0.01, shows that before and after treatment in patients has a significant difference.2. Second symptomsThrough chi-square test,42 cases had return visit, P=0.262>0.05, the results of second symptoms before and after treatment suggest no statistical significance (P=0.262> 0.05). However, the score before treatment is 77, and after treatment is 53. A reduction of 31.17%in this treatment.3. Secondary inspectionFollicular development situation:26 cases of which menopause is beyond the 35 days have ultrasound-record, the dominant follicle in 6 cases (23.08%); treatment with ultrasound-record number of cases,28 cases (period within 35 days and less) dominant follicle in 13 cases (46.43%), 13 patients had dominant follicle,9 cases which the emergence of the cycle within 14 days and (69.23%), and 4 cases are matured follicle.4. Follow up (1) Follow-up were 42 cases of post-treatment period, end of treatment, after 3 menstrual cycles,22 patients (52.38%) returned to normal period, 10 patients (23.81%) with shorter length of period(7 days or more) than before treatment, and 3 cases pregnancy(7.14%).(2) Follow-up were 34 cases of those with no significant associated syndrome, end of treatment, after 3 menstrual cycles,17 patients (50.00%) returned to normal period,8 patients(23.53%) with shorter length of period (7 days or more) than before treatment, and 2 cases pregnancy (5.88%).5. Clinical cases(1)At the end of treatment:of 53 patients with post-treatment period, 4 cases(7.55%)were cure,30 cases (56.60%)were apparent effective,11 cases(20.75%)were effective,8 cases(15.09%)were invalid. The total effective rate was 84.91%. Of 42 patients with no significant associated syndrome,4 cases(9.52%)were cure,26 cases(61.90%)were apparent effective,6 case(14.29%)was effective,6 case(14.29%)was invalid. The total effective rate was 85.71%.(2)After 3 period of ending-treatment, of 42 patients with post-treatment period,6 case(14.29%)were cured,17 cases (40.48%)were apparent effective,10 cases (23.81%) were effective,9 cases (21.43%)were invalid. The total effective rate was 78.57%. Of 34 patients with no significant associated syndrome,5 cases(14.71%)were cured,13 cases(38.24%)were apparent effective,8 cases(23.53%) were effective, 8 case(23.53%)was invalid. The total effective rate was76.47%.6. Correlation analysisThe chi-square test, comparison of the efficacy of the age, disease stage, and pregnancy cases, shows no statistic significant.Conclusion:First, "shenguijingxue soup "to treat late menstruation deficiency has the preliminary efficacy. It also has the preliminary efficacy when treating those who has no significant associated syndrome in late menstrual patients. Second, the essence, qi and blood deficiency alternation in each of the clinical treatment of late menstruation treatment has the positive guidance meaning. Third, the emphasis on "kidney yang" on the late period is worth studying.
Keywords/Search Tags:shengui jingxue soup, late menstruation, clinical analysis
PDF Full Text Request
Related items